Vitalhub Corp. (TSE:VHI) has released an update.
VitalHub Corp. has announced a robust start to 2024 with a 21% rise in both ARR and total revenue, reaching $47.8 million and $15.3 million respectively, alongside a notable 56% increase in EBITDA to $3.1 million. The company has attributed this growth to operational excellence, strategic acquisitions, and a strong commitment to innovation in healthcare technology. With a solid cash balance and a strategy focused on market expansion and product enhancement, VitalHub is poised for continued growth in the digital healthcare sector.
For further insights into TSE:VHI stock, check out TipRanks’ Stock Analysis page.
